Send the following on WhatsApp
Continue to ChatIntraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study--INTERACT MESO http://bmjopen.bmj.com/cgi/content/short/12/6/e062907?rss=1